The regulator of calcineurin 1 (RCAN1) inhibits CN (calcineurin), a Ca 2+ -activated protein phosphatase important in cardiac remodeling. In humans, RCAN1 is located on chromosome 21 in proximity to the Down syndrome critical region. The hearts and brains of Rcan1 KO mice are more susceptible to damage from ischemia/ reperfusion (I/R); however, the underlying cause is not known. 
C ardiovascular disease is the leading cause of death worldwide. 1 Restoring blood flow as soon as possible after a myocardial infarction or stroke is essential. However, reperfusion of ischemic tissue (ischemia/reperfusion [I/R]) can itself cause damage through generation of reactive oxygen species (ROS) and Ca 2+ overload. Mitochondrial function is a critical determinant of the susceptibility of the heart to I/R damage. [2] [3] [4] Mitochondria form dynamic networks whose structure is fashioned by the opposing processes of mitochondrial fission and fusion. 5 Increased fusion tends to increase mitochondrial membrane potential (∆Ψ m ) as well as the ∆Ψ m -dependent processes of ATP generation, ROS generation, and mitochondrial Ca 2+ uptake. An array of proteins are involved in the fission/fusion process, including the fission protein, dynamin-1-like (DNM1L, typically referred to as DRP1). Diverse posttranslational modifications of DRP1 regulate its activity, 6, 7 including dephosphorylation by the Ca
2+
-activated protein phosphatase, CN (calcineurin), that promotes DRP1 translocation to mitochondria, thereby initiating fission. 8 There is a dramatic increase in cytoplasmic Ca 2+ during ischemia; however, CN remains relatively inactive because of the low pH caused by a buildup of lactic acid.
9 CAPN (calpains) are Ca
-activated proteases that also play an important role in I/R damage. 10, 11 Similar to CN, they remain inactive in the low pH environment of the ischemic heart but are activated rapidly on reperfusion.
Sustained activation of CN is sufficient to drive pathological hypertrophy of the myocardium, with subsequent heart failure and death. 12 CN activity can be modified by members of the RCAN (regulator of calcineurin) family of proteins that inhibit CN activity through a direct protein-protein interaction. 13, 14 The regulator of calcineurin 1 (RCAN1) gene encodes 2 isoforms and was initially designated as Down syndrome (DS) critical region 1 (DSCR1) because of its location on human chromosome 21. 15 Altered mitochondrial function and increased oxidative stress have long been associated with DS. 16 Exon 1 isoform of RCAN1 (RCAN1.1) is abundant in striated muscle and brain where its expression is relatively constant, whereas expression of exon 4 isoform of RCAN1 (RCAN1.4) is under the control of CN, thereby acting as a feedback inhibitor of CN activity. 17 Cardiac-specific overexpression of an RCAN1 transgene protects the heart from a variety of pathological stresses including I/R, [18] [19] [20] whereas the brains and hearts of mice lacking RCAN1 are more sensitive to I/R. [21] [22] [23] Here, we investigate the contribution of RCAN1 to the control of mitochondrial dynamics and function using neonatal rat ventricular myocytes (NRVMs), isolated adult mouse ventricular cardiomyocytes (AMVM), mouse embryonic fibroblasts (MEF), and induced pluripotent stem cells (iPSC) derived from individuals 
Novelty and Significance
What Is Known?
• The regulator of calcineurin 1 gene (RCAN1), located on human chromosome 21, encodes a protein that inhibits the protein phosphatase calcineurin.
• Excessive activation of calcineurin in the heart contributes to pathological hypertrophy and the progression to failure.
• Calcineurin promotes mitochondrial fission by dephosphorylating the pro-fission protein DRP1 (dynamin-1-like).
• The hearts and brains of mice lacking RCAN1 are more susceptible to damage from ischemia/reperfusion. • Down syndrome, a condition caused by triplication of chromosome 21, has been associated with altered mitochondrial function and increased oxidative stress.
What New Information Does This Article Contribute?
• The mitochondrial network is more fragmented in cells deficient for RCAN1 because of a calcineurin-dependent increase in DRP1 activation and mitochondrial fission.
• Cardiomyocytes deficient for RCAN1 have decreased mitochondrial membrane potential, O 2 consumption, generation of reactive oxygen species, and capacity for mitochondrial Ca 2+ uptake.
• This reduces the capacity of mitochondria to buffer cytosolic Ca 2+ , thereby increasing damage from Ca 2+ -activated calpain proteases on reperfusion.
• Overexpression of the RCAN1.1 isoform is sufficient to generate a more fused network and increase oxygen consumption.
• Mitochondria in trisomic induced pluripotent stem cells derived from individuals with Down syndrome are larger and more metabolically active than isogenic, disomic controls. Furthermore, siRNA depletion of RCAN1.1 is sufficient to restore the mitochondrial network and function.
Mitochondria carry out critical functions beyond making ATP, such as acting as sites for Ca 2+ uptake and mediating cell death or survival. Here we show that RCAN1 helps maintain a functional mitochondrial network in cardiomyocytes and other cell types both in vitro and in vivo. Loss of RCAN1 increases mitochondrial fission while decreasing the capacity for Ca 2+ uptake. This leaves tissues more susceptible to calpain-mediated damage after ischemia/reperfusion, as occurs with heart attack or stroke. Conversely, excess RCAN1 is sufficient to promote fusion and increase mitochondrial metabolism. Although this is beneficial in the heart, we postulate that in the context of Down syndrome, where RCAN1 levels are chronically elevated, enhanced fusion may both increase generation of reactive oxygen species and interfere with the process of mitochondrial repair. 
Methods
Full methods are provided in the Online Data Supplement. All data, methods, and study materials are also available on request by contacting either Dr Parra (vparra@ciq.uchile.cl) or Dr Rothermel (beverly. rothermel@utsouthwestern.edu).
Results

Depletion of RCAN1 Increases Mitochondrial Fragmentation in Cardiomyocytes
Transmission electron micrographs comparing wild-type (WT) and Rcan1 KO hearts showed evidence of increased mitochondrial fragmentation in the KO ( Figure 1A ). There was a decrease in the size of individual mitochondria ( Figure 1B ) and an increase in their number ( Figure 1C ). Mitochondrial perimeter decreased ( Figure 1D ), whereas their circularity index increased ( Figure 1E ). To test whether RCAN1-dependent changes in the mitochondrial network were cell-autonomous, siRNAs were used to deplete the RCAN1.1 and RCAN1.4 isoforms from cultured NRVMs, either individually or in combination (dKD) (Online Figure I ). Forty-eight hours after siRNA transfection, cells were stained with Mitotracker Green (400 nmol/L; Figure 2A ) and quantified for both the number and size of individual mitochondria using volume-reconstitution of confocal Z stacks. [24] [25] [26] Consistent with the changes observed in the left ventricular wall of KO mice, dKD increased mitochondrial number ( Figure 2B ) and decreased size ( Figure 2C ). Depleting RCAN1.1 alone resulted in changes comparable to the dKD, whereas the effect of depleting RCAN1.4, although trending in a similar direction, was not significant. Thus, in this experimental context, the RCAN1.1 isoform had the primary impact on mitochondrial morphology. Electron micrographs of the siRNA-depleted NRVMs showed similar changes (Online Figure IIA through IIE) .
Fluorescence recovery after photo bleaching was used to compare the functional connectivity of mitochondria. siRNAtransfected NRVMs were labeled with tetramethylrhodamine followed by photo bleaching of selected regions of the mitochondrial network ( Figure 2D ). Fluorescence recovery after photo bleaching signal was quantified over time. The rate of recovery and the maximal fluorescence recovered were lower in RCAN1.1-depleted NRVMs compared with controls ( Figure 2E through 2G) , indicative of decreased mitochondrial connectivity or a lower efficiency for mitochondrial membrane potential recovery. There was no apparent change in total mitochondrial mass, as assessed by either Western blot or flow cytometry (Online Figure IIF through IIH) .
Depletion of RCAN1 Increases Translocation of DRP1 to Mitochondria
We postulated that loss of CN inhibition in the Rcan1 KO promotes mitochondrial fission by increasing CN activation of DRP1. Consistent with this, there was an increase in DRP1 protein in the mitochondrial fraction of RCAN1.1-depleted and dKD NRVMs compared with control siRNA or RCAN1.4-depleted NRVMs ( Figure 2H and 2I). DRP1 phosphorylation at serine 637, the CN substrate site (Ser 637 in humans and Ser 656 in rat), was assessed by immunoprecipitating total DRP1 and then probing with a phosphoSer 637 -specific antibody. NRVMs depleted for RCAN1.1 alone or as the dKD showed a decrease in Ser 637 phosphorylation compared with control siRNA and RCAN1.4-depleted cells ( Figure 2J and 2K). Taken together, the changes in phosphorylation and subcellular distribution of DRP1 suggest that RCAN1 helps maintain mitochondrial fusion by suppressing CN-mediated activation of DRP1 and points to the RCAN1.1 isoform playing a primary role in this process. Consistent with RCAN1 acting through CNdependent control of DRP1, pharmacological inhibition of CN using FK506, or inhibition of DRP1 using Mdivi-1, restored a more fused mitochondrial network to RCAN1.1-depleted NRVMs (Online Figure IIIA through IIIF) . To verify the impact of RCAN1 depletion on CN activity, we assessed nuclear translocation of endogenous NFAT1, which increased in RCAN1-depleted NRVMs, indicative of 
Mitochondrial Function Is Reduced in Cardiomyocytes Depleted of RCAN1.1
Disruption of the mitochondrial network is often associated with a decrease in mitochondrial function. 5, 27, 28 Indeed, intracellular ATP ( Figure 3A ) and ∆Ψ m ( Figure 3B ) were significantly reduced in the RCAN1.1-depleted and dKD NRVMs. ∆Ψ m is generated by proton pumping through the mitochondrial electron transport chain (ETC) at complexes (I, III, and IV) and then dissipated through complex V to generate ATP (OXPHOS coupling; Figure 3C ). Dissipation of the proton gradient can also occur through other mechanisms, some of which consume ATP. Thus, reductions in ∆Ψ m and ATP levels per se do not necessarily indicate a reduction in mitochondrial activity. The rate of O 2 consumption was used to assess electron flow through the ETC and fidelity of OXPHOS coupling. Baseline O 2 consumption was reduced in RCAN1.1-depleted and dKD NRVMs compared with control ( Figure 3D ). O 2 consumption was lower in RCAN1.1-depleted cells compared with controls, even after the addition of the uncoupler, carbonyl cyanide m-chlorophenylhydrazone, indicating a decrease in maximal ETC capacity ( Figure 3E ). There was no difference between control and RCAN1.1-depleted cells treated with the complex V inhibitor, oligomycin, demonstrating that loss of RCAN1.1 did not alter OXPHOS coupling. Consequently, oligomycin increased ∆Ψ m in both control and RCAN1.1-depleted cells (Online Figure IVA) . ROS production was also lower in the RCAN1.1-depleted and dKD cells compared with control ( Figure 3F and 3G), consistent with a reduction in both their ETC capacity and ∆Ψ m . It is important to note that mitochondria depleted for RCAN1.1 had the same rate of uncoupled proton leak as control cells, despite a lower driving force; ergo, they may be intrinsically leakier. If so, this could further contribute to reducing mitochondrial function and ROS production.
Transcript levels for several genes associated with glycolysis increased, including hexokinase 2 (Hk2), 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (Pfkfb2), and solute carrier family 2 member 1 (Slc2a1, also known as Glut1; Figure 3H ), suggesting that the RCAN1.1-depleted and dKD NRVMs may compensate for a reduction in mitochondrial function by increasing reliance on glycolysis. The survival rate of RCAN1.1-depleted NRVMs after a shift to media lacking glucose was reduced compared with control cells (Online Figure IVB) . There was no change in transcript levels of the mitochondrial ATPase synthase beta subunit (Atp5b), consistent with a reduction in mitochondrial efficiency rather than a change in total mitochondrial mass. Treatment with either FK506 or Mdivi-1 was sufficient to prevent the increase in expression of glycolytic genes in RCAN1-depleted NRVMs (Online Figure IVC through IVH) .
Increased Mitochondrial Fragmentation Increases Susceptibility of RCAN1.1-Depleted Cardiomyocytes to I/R
Tissues of the Rcan1 KO mice are more susceptible to damage from I/R. [21] [22] [23] To examine this in a controlled experimental system, we turned to an in vitro model of simulated cardiac I/R (sI/R). NRVMs depleted of RCAN1 were more sensitive to sI/R ( Figure 4A Abundance of the mitochondrial protein mtHSP70 (HSPA9 [heat shock protein family A (Hsp70) member 9]) was similar in control and RCAN1-depleted NRVM both prior to and after The complex V inhibitor, Oligomycin (Oligo, 10 μmol/L), and the mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP; 50 μmol/L) were used as positive and negative controls, respectively (n=5). C, Schematic draws an analogy between mitochondrial electron transport and an electric circuit. Complexes I, III, and IV act in parallel with respect to the proton circuit and in series with respect to the electron flow. The sites of action for Oligo and CCCP are indicated. D, O 2 consumption is reduced with RCAN1 depletion (n=6). E, Maximal and proton leak-associated O 2 consumption were assessed by adding CCCP (200 nmol/L) or Oligo (50 nmol/L), respectively (n=4). F, Total reactive oxygen species (ROS) content was measured by flow cytometry using MitoSox (n=5) or (G) DH123 (n=4). H, Transcript levels for hexokinase 2 (Hk2), 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 (Pfkfb2), solute carrier family 2 member 1 (Slc2a1), and mitochondrial ATPase synthase beta subunit (Atp5b) were quantified by quantitative polymerase chain reaction (qPCR; n=3). Mean±SEM; *P<0.05, **P<0.01, ***P<0.001. RCAN1 indicates regulator of calcineurin 1.
sI/R ( Figure 4D) suggesting that, at the time points measured, loss of RCAN1 did not alter total mitochondrial mass. Total DRP1 protein levels also remained constant ( Figure 4D and 4E). In contrast, levels of all isoforms of the fusion protein, OPA1 (mitochondrial dynamin-like GTPase), were reduced in the RCAN1.1-depleted and dKD NRVMs, both under normoxic conditions and after sI/R ( Figure 4D and 4F) . There was also an increase in levels of the PINK1 (PTEN-induced putative kinase 1) 29 in the RCAN1.1-depleted and dKD NRVMs, under both normoxic conditions and after I/R ( Figure 4D and 4G). Protein levels for the fusion protein, MFN2 (mitofusin 2), were not different under normoxic conditions, but after sI/R, there was a much more pronounced decline in MFN2 in the RCAN1.1-depleted cells compared with controls ( Figure 4D and 4H ). These changes in OPA1 and MFN2 levels would favor fission and may, therefore, act to further disrupt the mitochondrial network in RCAN1-depleted cells. Figure 5A ; Online Figure V) , a region of close interaction between mitochondria and the endoplasmic reticulum. To assess capacity for mitochondrial Ca 2+ uptake, NRVMs were loaded with RhodFF and then treated with histamine to evoke Ca 2+ release from the endoplasmic reticulum. Mitochondrial Ca 2+ uptake was significantly reduced in RCAN1.1-depleted cells compared with siRNA controls (Figure 5B and 5C) . To test the impact on cytosolic Ca 2+ transients in the setting of calcium-induced calcium release, NRVMs were loaded with Fura2 and then stimulated with 50 mmol/L KCl to depolarize the plasma membrane and trigger calcium-induced calcium release. Cytoplasmic Ca 2+ levels were similar in RCAN1.1-depleted and control cells at rest. After KCl stimulation, a rapid increase in cytosolic Ca 2+ was observed in both cell types. However, cytosolic Ca 2+ returned to baseline levels in the control NRVMs, whereas in the RCAN1.1-depleted cells, cytosolic Ca 2+ levels remained elevated ( Figure 5D and 5E). The increases in cytosolic Ca 2+ after histamine treatment were also much higher in RCAN1.1-depleted NRVMs compared with those in controls (Online Figure VIA and VIB) . 32, 33 and contribute to the degradation of several structural proteins in cardiomyocytes after I/R, including SPTAN1 (α-spectrin). 34, 35 An increase in the levels of SPTAN1 cleavage products after sI/R verified activation of CAPNs in our model ( Figure 5F ). The accumulation of cleavage products after sI/R was greater in the RCAN1.1-depleted cells than in . E-64D and MDL also inhibit cathepsins. 36 PD 150606 is more specific, inhibiting both CAPN 1 and 2 (μ-CAPN and m-CAPN), which are the primary forms found in heart. 34 Targeted siRNAs were used to knock down both Capn 1 and 2. This conferred significant protection to the RCAN1.1-depleted NRVMs ( Figure 5J ; Online Figure VIH through VIJ) . Preincubation of NRVMs with Ruthenium Red (RuRed), an inhibitor of mitochondrial Ca 2+ uniporter, increased cell death under normoxia and after I/R in RCAN1.1-depleted cells, whereas, chelating intracellular Ca 2+ with BAPTA-AM prior sI/R reduced death (Online Figure VIK through VIO) . Taken together, these results suggest that NRVMs deficient for RCAN1.1 are more susceptible to damage from I/R because of elevated activation of CAPN after reperfusion and that this may be because of a decrease in mitochondrial Ca 2+ buffering capacity, the result of enhanced fission.
The Capacity for Mitochondrial
Increasing RCAN1.1 Levels Is Sufficient to Promote Cardiomyocyte Mitochondrial Fusion and Increase O 2 Consumption
An adenovirus encoding full-length human RCAN1.1 (AdhRCAN1.1) was used to test whether increasing RCAN1.1 levels is sufficient to increase mitochondrial fusion (Online Figure VIIA and VIID) . Twenty-four hours after infection, Ad-hRCAN1.1 restored mitochondrial fusion to the RCAN1.1-depleted cells in a dose-dependent fashion ( Figure 6A through  6C) . In contrast, infection with an adenovirus encoding the RCAN1.4 isoform (Ad-hRCAN1.4) was not sufficient to restore the mitochondrial network to RCAN1.1-depleted NRVMs (Online Figure VIIIA through VIIIG) . Ad-hRCAN1.1 also increased fusion in control siRNA cells, demonstrating that increasing RCAN1 levels is sufficient to promote fusion. Consistent with the changes seen in mitochondrial morphology, Ad-hRCAN1.1 increased O 2 consumption ( Figure 6D ), ROS generation ( Figure 6E ), and conferred protection from sI/R ( Figure 6F ). In contrast, Ad-hRCAN1.4 did not confer significant protection (Online Figure VIIIH) . Although Ad-hRCAN1.1 infection of control cells increased O 2 consumption, this was at least in part caused by an increase in uncoupling (+oligomycin in Figure 6G ) rather than a change in the capacity for maximal electron flow through the ETC (+carbonyl cyanide m-chlorophenylhydrazone in Figure 6G ).
Loss of RCAN1 In Vivo Decreases Mitochondrial Metabolism and the Capacity for Mitochondrial Ca 2+ Uptake and Function in Adult Cardiomyocytes
To determine whether our findings in NRVMs translated to the adult myocardium, AMVM were isolated from adult WT and KO mice and evaluated to compare mitochondrial morphology, capacity for Ca 2+ uptake, and metabolic activity. Despite the compact organization of the mitochondrial network, 3D reconstruction revealed a more fragmented network in KO myocytes compared with WT, with an increase in the total number of mitochondria per cell and a decrease in mitochondrial size ( Figure 7A through 7C) . Interestingly, separate analysis of interior regions of interest verses peripheral regions of interest suggested that increased fission in the KO localized primarily to mitochondrial populations located in the interior of cardiomyocytes, whereas peripheral populations were not significantly different between KO and WT ( Figure 7A, 7D, and 7E) . Directly relevant to the increase in I/R sensitivity, the capacity for mitochondrial calcium uptake was significantly reduced in KO AMVM compared with WT ( Figure 7F through 7H) . The localization of the Ca 2+ signal was consistent with mitochondrial morphology. Uptake by mitochondrial Ca 2+ uniporter was validated using the inhibitor RuRed (Online Figure IX) . O 2 consumption was measured in permeabilized AMVM. State III respiration was significantly lower in AMVM from the Rcan1 KO compared with those from WT using either pyruvate ( Figure 7I ) or glutamate ( Figure 7J ) as a substrate. Taken together, these findings indicate that loss of RCAN1 in adult cardiomyocytes replicates many of the key features observed in NRVMs.
Mitochondrial Fusion Is Increased in iPSC Derived From Individuals With Down Syndrome
The preceding studies provide evidence that RCAN1 helps to maintain the mitochondrial network in a more fused configuration and that this affects fundamental metabolic parameters in cardiomyocytes. To determine whether these findings extend to other cell types, we first isolated MEF from the Rcan1 KO and compared the mitochondrial network to that of WT MEF. Consistent with the studies in RCAN1-depeleted NRVMs, the mitochondrial network in Rcan1 KO MEF showed evidence of increased fission compared with that of WT MEF (Online Figure X) ; thus, RCAN1's impact on mitochondrial dynamics was not specific to cardiomyocytes. Our studies overexpressing RCAN1.1 in NRVMs also suggest that increasing RCAN1 levels beyond their normal homeostatic controls is not necessarily beneficial and can have detrimental consequences with regard to increased uncoupling and ROS generation ( Figure 6 ).
To examine this in the context of human health and disease, we turned to individuals with DS who are trisomic for chromosome 21. RCAN1 protein levels are elevated in the brain human fetuses with DS, 15, 37 and studies have linked RCAN1 with oxidative stress respnses. [38] [39] [40] We obtained human trisomy 21 iPSCs (T21-iPSC) and isogenic disomic controls (D21-iPSC) through the PCBC Disease Lines resource (https://progenitorcells.org/). 41 Mitochondrial morphology was assessed and showed a reduction in the number of mitochondria per cell and an increase in the mean volume of individual mitochondria in trisomic T21-iPSC when compared with disomic D21-iPSC, indicative of a more interconnected mitochondrial network (Figure 8A through 8C) . The rate of O 2 consumption was also substantially elevated in the T21-iPSC ( Figure 8D) . O 2 consumption did not further increase after addition of carbonyl cyanide m-chlorophenylhydrazone, suggesting that the mitochondria in these cells are already working at maximal capacity. Importantly, there was also an increase in uncoupled proton leak in the T21-iPSC similar to that observed in control NRVMs infected with Ad-hRCAN1.1 (Figure 6 ), suggesting that increased dosage of RCAN1 may have detrimental effects on mitochondrial function.
Although chromosome 21 is the smallest of the human somatic chromosomes, it contains over 200 genes along with an array of noncoding RNAs, any one, or combination of, could contribute to this change in mitochondrial morphology and function. To test whether increased dosage of the RCAN1 gene underlies the changes in mitochondrial form and function, human-specific siRNAs were used to deplete each of the RCAN1 isoforms individually and in combination from the trisomic T21-iPSC. At baseline, transcript levels for RCAN1.1 were elevated in the T21-iPSC compared with those in the disomic D21-iPSC ( Figure 8E ). The disomic and trisomic iPSC were transfected with siRNAs targeting RCAN1.1 and RCAN1.4 alone or in combination. siRNA targeting RCAN1.1 was effective at reducing RCAN1.1 transcript levels in both genotypes ( Figure 8E ). In the T21-iPSC, transcript and protein levels for RCAN1.1 were reduced to at, or below, those found in D21-iPSC ( Figure 8E through 8G) . This occurred without impacting markers of pluripotency as assessed by Western blot (Figure 8F ) or quantitative reverse transcriptase polymerase chain reaction (Online Figure XI) . RCAN1.4 protein was below the level of detection in these cells ( Figure 8F ). Remarkably, siRNA depletion of RCAN1.1 was sufficient to restore the mitochondrial network in the T21-iPSC to levels comparable to control siRNA-transfected D21-iPSC ( Figure 8H through 8J) . The rate of O 2 consumption in T21-iPSC was likewise restored to that measured in D21-iPSC ( Figure 8K ). Taken together, these data suggest that increased dosage of RCAN1 may underlie a fundamental increase in mitochondrial fusion in the setting of trisomy 21 but may come at the cost of compromised coupling efficiency and reduced respiratory reserve.
Discussion
Mitochondrial metabolism and function play an important role in human health, disease, and aging. This is particularly true in highly oxidative organs such as the heart and brain where mitochondrial dysfunction is often a prominent feature of disease-related decline. In the setting of reperfusion injury after acute MI or stroke, mitochondria are the source of fundamental signals mediating cellular survival and death. In the context of RCAN1 deficiency, cardiac and neuronal damage after I/R is greater in Rcan1-KO mice, and forced expression in either 10 μm) . B, Trisomic T21-iPSC contained fewer (C) and larger mitochondria compared with disomic D21-iPSC. Data are from 25 cells in 3 independent experiments. D, O 2 consumption rate was higher in T21-iPSC than in D21-iPSC. Maximal capacity and proton leak were assessed by adding oligomycin (Oligo; 50 nmol/L) or carbonyl cyanide m-chlorophenylhydrazone (CCCP; 200 nmol/L), respectively (n=5). E, Transcript levels for exon 1 isoform of RCAN1 (RCAN1.1) were higher in T21-iPSC than in D21-iPSC. Human-specific siRNAs targeting each of the RCAN1 isoforms were used to deplete endogenous RCAN1 from both lines and changes in endogenous RCAN1.1 transcripts quantified by qPCR (n=4). F, The siRNA-depleted iPSC were analyzed by Western blot for RCAN1, SOX2, POU5F1, and TUBB proteins. HEK293 cells were used as controls. G, Densitometry was used to quantify RCAN1.1 protein levels in F normalized to TUBB (n=4). H, Trisomic T21-iPSC were depleted of RCAN1.1 and RCAN1.4, individually and in combination (dKD), and then stained for analysis of the mitochondrial network (scale bar: 10 μm). I, Depletion of RCAN1.1 alone or in combination with RCAN1.4 (dKD) increased mitochondrial number, (J) reduced average mitochondrial size, and (K) reduced basal reactive oxygen species (ROS) generation to levels (n=5). Mean±SEM; *P<0.05, **P<0.01, ***P<0.001. POU5F1 indicates POU class 5 homeobox; RCAN1, regulator of calcineurin 1; SOX2, SRY-box 2; and TUBB, β-tubulin. e31 cardiomyocytes or neurons can confer protection. [21] [22] [23] 42 Here, we provide evidence that altering the levels of RCAN1 has a direct impact on mitochondrial dynamics. Based on these findings, we propose that the following cascade of events underlies the increase in sensitivity to reperfusion damage: In the absence of inhibition by RCAN1, increased CN activity promotes DRP1-mediated mitochondrial fission. The increase in fission decreases ∆Ψ m and metabolic activity, lowering the capacity for mitochondrial Ca 2+ uptake. Our studies suggest that, as a consequence, buffering of cytosolic Ca 2+ is reduced, thereby, increasing CAPN-mediated damage after reperfusion. Although both cytosolic and mitochondrial localized CAPN can cause cellular damage, in the context of RCAN1 deficiency, the relevant pool, or pools, of CAPN are most likely cytosolic (Online Figure XII) .
The reduction in OPA1 protein levels seen in RCAN1-depleted NRVMs is consistent with lower ∆Ψ m , as decreased membrane potential promotes OPA1 cleavage and degradation. Because of OPA1's role in mitochondrial fusion, the decline in OPA1 abundance may further shift the mitochondrial population toward fission in RCAN1-deficient cells. An increase in PINK1 protein is likewise consistent with reduced ∆Ψ m as membrane potential is required for translocation of PINK1 into the mitochondrial matrix for subsequent degradation. Activation of PINK1 can initiate tagging of mitochondria for degradation via mitophagy. However, we saw no reduction in total mitochondrial mass in RCAN1-depleted cells, suggesting that the increase in PINK1 was either not sufficient to increase mitochondrial degradation or that an increase in mitochondrial biogenesis compensated for increased catabolism.
ROS generation during reperfusion is a well-documented mediator of I/R damage. However, the decrease in basal ROS activity and decline in maximal ETC capacity in the RCAN1-depleted NRVMs (Figure 3 ) would suggest that ROS-mediated damage may not be the primary mechanism mediating increased I/R sensitivity in culture. That does not preclude a mechanism involving elevated ROS in the context of the working heart and neurons where energetic demands might drive an increase in mitochondrial content to compensate for the decline in mitochondrial efficiency.
Our studies suggest that RCAN1.1 is the primary isoform impacting mitochondrial dynamics and function. However, in our experiments, the protein levels following Ad-hRCAN1.1 infection were an order of magnitude higher than for AdhRCAN1.4 (Online Figure VIIC and VIID and VIIIC and VIIID), thus, limiting the ability to draw definitive conclusions regarding isoform specificity based on the adenoviral complementation studies. The 2 isoforms are comparable in their ability to inhibit CN in biochemical assays, although some isoform-specific properties have been reported in vivo. For instance, we recently demonstrated an isoform-specific role for RCAN1.4 in the process of VEGF receptor internalization. 43 In our studies, forced expression of RCAN1.1 was sufficient to increase mitochondrial fusion and confer protection from sI/R to both RCAN1.1-depleted and control siRNAtransfected NRVMs (Figure 6 ). Although overexpression using adenoviruses increased RCAN1.1 levels well over those of the endogenous protein, the studies comparing trisomic T21-iPSC to disomic D21-iPSC demonstrate that modest changes in RCAN1 levels can have a meaningful impact on mitochondrial dynamics and function. Altered mitochondrial function and increased oxidative stress have long been associated with DS. 16 Although there is no universal agreement regarding morphological changes to the mitochondrial network in trisomic tissues, an increase in mitochondrial ROS generation is widely reported and would be consistent with the increased fusion observed in the T21-iPSC. In addition, increased mitochondrial Ca 2+ levels are documented in both heart and cultured fibroblasts from DS fetuses. 44 Our findings point toward a mechanism through which increased RCAN1 dosage could underlie these changes.
In the context of I/R damage, these studies suggest that increased fusion protects cardiomyocytes by reducing the extent of CAPN activation after reperfusion. However, a sustained increase in fusion may also have negative consequences. Indeed, although an increase in ∆Ψ m increased the capacity for ATP generation, it also increased the capacity for ROS generation, thereby, increasing the potential for cellular damage. Sustained fusion could also slow the process of mitochondrial turnover and repair. Over time, these 2 mechanisms would act to fuel the generation and accumulation of damaged mitochondrial components. This may be the underlying cause of the increase in uncoupling observed in both trisomic T21-iPSC and NRVMs infected with Ad-hRCAN1.1. Alternative explanations for the decline in coupling efficiency are activation of protective compensatory mechanisms or a direct impact of RCAN1 on mitochondrial coupling. Along these lines, it is relevant to note that RCAN has been reported to interact both directly 45 and indirectly 46 with the adenine nucleotide translocase, a protein which can act to uncouple the inner mitochondrial membrane proton gradient. 47 Transgenic overexpression of RCAN1 is reported to increase mitochondrial ROS in both neurons and pancreatic islets. 48, 49 Under normal glucose conditions, ∆Ψ m is elevated in islets overexpressing RCAN1 but is depressed in response to elevated glucose. 50 Thus, changes mediated by RCAN1 may be context dependent. As an example, we recently showed that brain-specific overexpression of RCAN1.1 caused agedependent cognitive impairments similar to early-onset dementia seen in individuals with DS. 51 Mitochondrial ROS and the number of large, globular mitochondria increased in the brains of these animals; consistent with the mechanism we report here, however, there was also an accompanying, agedependent decline in DRP1 phosphorylation, not predicted by our model. We postulate that this may be the combined outcome of primary effects, cumulative damage, and compensatory mechanisms. The mitochondrial network of trisomic Ts21-iPSC may more closely represent primary fundamental differences in mitochondria dynamics because iPSC are predominately glycolytic and, therefore, not yet impacted by functional selection as might occur in the setting of an intact animal or even differentiated cell types in culture.
Taken together, our studies indicate a dose-dependent response of the mitochondrial network to changes in the availability of RCAN1. RCAN1 insufficiency favors fission, thereby, reducing mitochondrial metabolic activity and capacity for mitochondrial Ca 2+ uptake. In the case of RCAN1-depleted NRVM, this increases vulnerability to sI/R damage
